| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | stretch-activated, monoatomic cation-selective, calcium channel activity | 3.03e-05 | 3 | 64 | 2 | GO:0015275 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.85e-05 | 129 | 64 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.15e-04 | 465 | 64 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.23e-04 | 151 | 64 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.50e-04 | 6 | 64 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic cation channel activity | 2.10e-04 | 7 | 64 | 2 | GO:0140135 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.85e-04 | 40 | 64 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 7.71e-04 | 13 | 64 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.97e-04 | 343 | 64 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 8.50e-04 | 627 | 64 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | adenyl-nucleotide exchange factor activity | 1.03e-03 | 15 | 64 | 2 | GO:0000774 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.23e-03 | 664 | 64 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.50e-03 | 18 | 64 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 1.66e-03 | 73 | 64 | 3 | GO:0044183 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate kinase activity | 2.04e-03 | 21 | 64 | 2 | GO:0004550 | |
| GeneOntologyCellularComponent | pericentriolar material | 8.49e-05 | 28 | 64 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum lumen | 3.28e-04 | 9 | 64 | 2 | GO:0033018 | |
| Domain | FAM155 | 1.12e-05 | 2 | 63 | 2 | IPR029604 | |
| Domain | TPR | 7.42e-05 | 129 | 63 | 5 | SM00028 | |
| Domain | TPR_repeat | 8.57e-05 | 133 | 63 | 5 | IPR019734 | |
| Domain | Na/HCO3_transpt | 1.11e-04 | 5 | 63 | 2 | IPR003024 | |
| Domain | TPR-contain_dom | 1.51e-04 | 150 | 63 | 5 | IPR013026 | |
| Domain | TPR_REGION | 2.35e-04 | 165 | 63 | 5 | PS50293 | |
| Domain | TPR | 2.35e-04 | 165 | 63 | 5 | PS50005 | |
| Domain | TPR_1 | 2.42e-04 | 90 | 63 | 4 | PF00515 | |
| Domain | TPR_1 | 2.42e-04 | 90 | 63 | 4 | IPR001440 | |
| Domain | Band3_cytoplasmic_dom | 3.97e-04 | 9 | 63 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 3.97e-04 | 9 | 63 | 2 | PF07565 | |
| Domain | - | 3.97e-04 | 9 | 63 | 2 | 3.40.1100.10 | |
| Domain | Pept_M24 | 3.97e-04 | 9 | 63 | 2 | IPR000994 | |
| Domain | Peptidase_M24 | 3.97e-04 | 9 | 63 | 2 | PF00557 | |
| Domain | - | 3.97e-04 | 9 | 63 | 2 | 3.90.230.10 | |
| Domain | HCO3_cotransp | 4.95e-04 | 10 | 63 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 4.95e-04 | 10 | 63 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 4.95e-04 | 10 | 63 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 4.95e-04 | 10 | 63 | 2 | IPR003020 | |
| Domain | TPR_7 | 4.95e-04 | 10 | 63 | 2 | PF13176 | |
| Domain | - | 6.65e-04 | 207 | 63 | 5 | 1.25.40.10 | |
| Domain | - | 7.23e-04 | 12 | 63 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 7.23e-04 | 12 | 63 | 2 | IPR029047 | |
| Domain | TPR_8 | 7.60e-04 | 53 | 63 | 3 | PF13181 | |
| Domain | - | 8.53e-04 | 13 | 63 | 2 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 8.53e-04 | 13 | 63 | 2 | IPR018181 | |
| Domain | HSP70_C | 8.53e-04 | 13 | 63 | 2 | IPR029048 | |
| Domain | TPR-like_helical_dom | 1.13e-03 | 233 | 63 | 5 | IPR011990 | |
| Domain | HSP70 | 1.30e-03 | 16 | 63 | 2 | PF00012 | |
| Domain | HSP70_2 | 1.47e-03 | 17 | 63 | 2 | PS00329 | |
| Domain | HSP70_3 | 1.47e-03 | 17 | 63 | 2 | PS01036 | |
| Domain | HSP70_1 | 1.47e-03 | 17 | 63 | 2 | PS00297 | |
| Domain | Hsp_70_fam | 1.65e-03 | 18 | 63 | 2 | IPR013126 | |
| Domain | EF-hand_8 | 5.86e-03 | 34 | 63 | 2 | PF13833 | |
| Domain | Ion_trans_dom | 6.74e-03 | 114 | 63 | 3 | IPR005821 | |
| Domain | Ion_trans | 6.74e-03 | 114 | 63 | 3 | PF00520 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NPM1 PALD1 NEK1 NAMPT TCP1 FAM50A PA2G4 ARID2 HSPH1 PEPD YTHDC2 HSPA4 | 1.19e-07 | 934 | 64 | 12 | 33916271 |
| Pubmed | NPM1 MIA3 NAMPT SLC4A8 CAMKV GRAMD1A ADGRB3 GRIN2B SLC4A4 PTEN CXADR RYR2 | 9.80e-07 | 1139 | 64 | 12 | 36417873 | |
| Pubmed | NPM1 MIA3 NOP14 PDE7A PA2G4 CALU CTR9 GRAMD1A HSPH1 CEP192 PIBF1 HSPA4 CXADR | 2.60e-06 | 1487 | 64 | 13 | 33957083 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | NPM1 MIA3 TCP1 FAM50A PA2G4 HSPH1 ADGRB3 HSPA4 ERLIN1 DYNC1LI2 | 3.21e-06 | 847 | 64 | 10 | 35235311 |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15010472 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 36923153 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17951246 | ||
| Pubmed | PDE7A SATB1 KLHL7 CTR9 HSPH1 ADGRB3 GPSM2 GRIN2B CABIN1 TRIM37 DOP1B SOS1 | 3.42e-06 | 1285 | 64 | 12 | 35914814 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIA3 TCP1 KLHL7 HSPH1 CEP192 PIBF1 PPID TRIM37 ERLIN1 DYNC1LI2 | 3.42e-06 | 853 | 64 | 10 | 28718761 |
| Pubmed | Proteomic analysis of the NOS2 interactome in human airway epithelial cells. | 5.78e-06 | 138 | 64 | 5 | 23438482 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 23737532 | ||
| Pubmed | Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia. | 9.99e-06 | 3 | 64 | 2 | 23183427 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 36987811 | ||
| Pubmed | Prevalence and pathogenesis of Barrett's esophagus in Luoyang, China. | 9.99e-06 | 3 | 64 | 2 | 22901192 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 26167768 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 29032201 | ||
| Pubmed | KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis. | 9.99e-06 | 3 | 64 | 2 | 35354467 | |
| Pubmed | PALD1 NAMPT TCP1 PA2G4 CALU PLEKHG3 GRAMD1A HSPH1 YTHDC2 CABIN1 HSPA4 ERLIN1 | 1.08e-05 | 1440 | 64 | 12 | 30833792 | |
| Pubmed | 1.68e-05 | 27 | 64 | 3 | 21343306 | ||
| Pubmed | Spatial centrosome proteome of human neural cells uncovers disease-relevant heterogeneity. | 1.68e-05 | 27 | 64 | 3 | 35709258 | |
| Pubmed | LGN loss randomizes spindle orientation and accelerates tumorigenesis in PTEN-deficient epidermis. | 2.00e-05 | 4 | 64 | 2 | 37991903 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 22572802 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 22160715 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 10748157 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 27464702 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 18173745 | ||
| Pubmed | 2.06e-05 | 1049 | 64 | 10 | 27880917 | ||
| Pubmed | 2.12e-05 | 305 | 64 | 6 | 33194618 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 2.57e-05 | 31 | 64 | 3 | 20516061 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PALD1 NEK1 KLHL7 PA2G4 CTR9 TTC21A PIBF1 USH1C PPID ERLIN1 DYNC1LI2 | 2.66e-05 | 1321 | 64 | 11 | 27173435 |
| Pubmed | TRPM6 KMT2C MIA3 PA2G4 CTR9 HSPH1 CEP192 TRIM37 ERLIN1 DYNC1LI2 | 2.73e-05 | 1084 | 64 | 10 | 11544199 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 3.07e-05 | 195 | 64 | 5 | 17110338 | |
| Pubmed | PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning. | 3.32e-05 | 5 | 64 | 2 | 28636948 | |
| Pubmed | Proteostasis modulators prolong missense VHL protein activity and halt tumor progression. | 3.32e-05 | 5 | 64 | 2 | 23318261 | |
| Pubmed | Chromosome mapping of five human cardiac and skeletal muscle sarcoplasmic reticulum protein genes. | 3.32e-05 | 5 | 64 | 2 | 8406504 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 3.40e-05 | 332 | 64 | 6 | 30595499 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NPM1 NAMPT TCP1 FAM50A PA2G4 CALU HSPH1 PPID HSPA4 ERLIN1 PPL | 3.64e-05 | 1367 | 64 | 11 | 32687490 |
| Pubmed | CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1. | 3.72e-05 | 101 | 64 | 4 | 34462429 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 4.17e-05 | 208 | 64 | 5 | 33230847 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 24651434 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 36065190 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 15967112 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 5.10e-05 | 217 | 64 | 5 | 31685992 | |
| Pubmed | The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. | 5.20e-05 | 110 | 64 | 4 | 18307411 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 NPM1 NAMPT TCP1 PA2G4 CALU CTR9 HSPH1 PEPD YTHDC2 HSPA4 | 5.30e-05 | 1425 | 64 | 11 | 30948266 |
| Pubmed | 5.43e-05 | 725 | 64 | 8 | 27025967 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.58e-05 | 363 | 64 | 6 | 14691545 | |
| Pubmed | 5.81e-05 | 223 | 64 | 5 | 20020773 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NPM1 NAMPT TCP1 PA2G4 CALU CTR9 HSPH1 PEPD PPID HSPA4 DYNC1LI2 | 6.39e-05 | 1455 | 64 | 11 | 22863883 |
| Pubmed | 6.48e-05 | 963 | 64 | 9 | 28671696 | ||
| Pubmed | 6.56e-05 | 547 | 64 | 7 | 37267103 | ||
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 6.84e-05 | 118 | 64 | 4 | 37105989 | |
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 21664258 | ||
| Pubmed | A novel HSF1-mediated death pathway that is suppressed by heat shock proteins. | 6.96e-05 | 7 | 64 | 2 | 17024176 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 8.03e-05 | 565 | 64 | 7 | 33567341 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 8.76e-05 | 573 | 64 | 7 | 28330616 | |
| Pubmed | 8.79e-05 | 777 | 64 | 8 | 35844135 | ||
| Pubmed | 8.88e-05 | 244 | 64 | 5 | 30349055 | ||
| Pubmed | Quantitative assessment of complex formation of nuclear-receptor accessory proteins. | 9.27e-05 | 8 | 64 | 2 | 10642522 | |
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 11784029 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 9.42e-05 | 1257 | 64 | 10 | 36526897 | |
| Pubmed | 9.58e-05 | 248 | 64 | 5 | 32963011 | ||
| Pubmed | 9.92e-05 | 403 | 64 | 6 | 30562941 | ||
| Pubmed | APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process. | 1.19e-04 | 9 | 64 | 2 | 19188445 | |
| Pubmed | Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. | 1.19e-04 | 9 | 64 | 2 | 15004035 | |
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 17289029 | ||
| Pubmed | 1.26e-04 | 263 | 64 | 5 | 12665801 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.27e-04 | 422 | 64 | 6 | 27342126 | |
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 1.38e-04 | 54 | 64 | 3 | 31792442 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.39e-04 | 1318 | 64 | 10 | 30463901 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 1.40e-04 | 269 | 64 | 5 | 30442662 | |
| Pubmed | 1.49e-04 | 10 | 64 | 2 | 9222609 | ||
| Pubmed | 1.49e-04 | 10 | 64 | 2 | 19171884 | ||
| Pubmed | 1.54e-04 | 56 | 64 | 3 | 19299420 | ||
| Pubmed | 1.56e-04 | 146 | 64 | 4 | 21399614 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.60e-04 | 440 | 64 | 6 | 34244565 | |
| Pubmed | 1.64e-04 | 148 | 64 | 4 | 35676246 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.72e-04 | 1353 | 64 | 10 | 29467282 | |
| Pubmed | 1.81e-04 | 1103 | 64 | 9 | 34189442 | ||
| Pubmed | INKA2, a novel p53 target that interacts with the serine/threonine kinase PAK4. | 1.81e-04 | 11 | 64 | 2 | 31081062 | |
| Pubmed | CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder. | 1.81e-04 | 11 | 64 | 2 | 36385105 | |
| Pubmed | 1.98e-04 | 61 | 64 | 3 | 20305087 | ||
| Pubmed | 2.10e-04 | 463 | 64 | 6 | 34901782 | ||
| Pubmed | Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | 2.16e-04 | 159 | 64 | 4 | 36762613 | |
| Pubmed | 2.17e-04 | 12 | 64 | 2 | 21946088 | ||
| Pubmed | Respiratory distress and early neonatal lethality in Hspa4l/Hspa4 double-mutant mice. | 2.17e-04 | 12 | 64 | 2 | 23980576 | |
| Pubmed | Heat-shock protein HSPA4 is required for progression of spermatogenesis. | 2.17e-04 | 12 | 64 | 2 | 21487003 | |
| Pubmed | Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity. | 2.17e-04 | 12 | 64 | 2 | 19946338 | |
| Pubmed | 2.32e-04 | 162 | 64 | 4 | 25796446 | ||
| Pubmed | 2.33e-04 | 472 | 64 | 6 | 38943005 | ||
| Pubmed | 2.57e-04 | 13 | 64 | 2 | 20164180 | ||
| Pubmed | 2.57e-04 | 13 | 64 | 2 | 21502505 | ||
| Pubmed | 2.66e-04 | 1429 | 64 | 10 | 35140242 | ||
| Pubmed | 2.94e-04 | 493 | 64 | 6 | 15368895 | ||
| Pubmed | Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. | 2.99e-04 | 14 | 64 | 2 | 19037095 | |
| Pubmed | The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors. | 2.99e-04 | 14 | 64 | 2 | 19136632 | |
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 2.99e-04 | 14 | 64 | 2 | 28724790 | |
| Pubmed | 3.20e-04 | 708 | 64 | 7 | 39231216 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 3.32e-04 | 178 | 64 | 4 | 27637333 | |
| Pubmed | RNA Directed Modulation of Phenotypic Plasticity in Human Cells. | 3.45e-04 | 15 | 64 | 2 | 27082860 | |
| Interaction | MET interactions | 2.43e-07 | 290 | 62 | 9 | int:MET | |
| Interaction | APEX2 interactions | 7.55e-06 | 41 | 62 | 4 | int:APEX2 | |
| Interaction | CNTNAP2 interactions | 9.03e-06 | 158 | 62 | 6 | int:CNTNAP2 | |
| Interaction | TRIM37 interactions | NPM1 ZNF776 TCP1 SYTL4 PA2G4 CEP192 PIBF1 PTEN TRIM37 ERLIN1 | 2.06e-05 | 630 | 62 | 10 | int:TRIM37 |
| Interaction | LRRC4C interactions | 2.23e-05 | 110 | 62 | 5 | int:LRRC4C | |
| Interaction | NAA40 interactions | NPM1 PALD1 NEK1 NAMPT TCP1 FAM50A PA2G4 ARID2 HSPH1 PEPD YTHDC2 HSPA4 | 3.64e-05 | 978 | 62 | 12 | int:NAA40 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p24 | 5.42e-04 | 113 | 64 | 3 | chr3p24 | |
| Cytoband | 3p24.3 | 6.57e-04 | 27 | 64 | 2 | 3p24.3 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.73e-04 | 115 | 44 | 4 | 769 | |
| GeneFamily | Heat shock 70kDa proteins | 7.69e-04 | 17 | 44 | 2 | 583 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.92e-07 | 187 | 64 | 6 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.73e-07 | 195 | 64 | 6 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.47e-06 | 176 | 64 | 5 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.94e-06 | 179 | 64 | 5 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.27e-06 | 181 | 64 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 187 | 64 | 5 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 187 | 64 | 5 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 7.74e-06 | 189 | 64 | 5 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.74e-06 | 189 | 64 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.14e-06 | 191 | 64 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.35e-06 | 192 | 64 | 5 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 194 | 64 | 5 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.78e-06 | 194 | 64 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.78e-06 | 194 | 64 | 5 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 8.78e-06 | 194 | 64 | 5 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.00e-06 | 195 | 64 | 5 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | CV-Severe-2|CV / Virus stimulation, Condition and Cluster | 9.00e-06 | 195 | 64 | 5 | 1cde7f6e6c9c610bacc79014519447112c27dd9d | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.46e-06 | 197 | 64 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.93e-06 | 199 | 64 | 5 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.93e-06 | 199 | 64 | 5 | b65fbfed4a9938820cf900afd350b4ecb789b7b3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-05 | 200 | 64 | 5 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 97 | 64 | 4 | a1279377bf0ee5662db8b9303f5f1fd418dee6df | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 97 | 64 | 4 | 12cbd03b33e76e5e471bbee2a9c11f27e8b21123 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.22e-05 | 142 | 64 | 4 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 169 | 64 | 4 | 606aa4ff25380d9470ec116ca86cd20f8b19587a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 169 | 64 | 4 | 052aae2af5446a0de071d5dda5381b0b9a0ed54d | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 176 | 64 | 4 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 177 | 64 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 177 | 64 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 178 | 64 | 4 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 178 | 64 | 4 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 178 | 64 | 4 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 178 | 64 | 4 | 523b286ebe0359c7f1902f28cbd71f452626fc0d | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.28e-04 | 179 | 64 | 4 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 180 | 64 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 181 | 64 | 4 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.36e-04 | 182 | 64 | 4 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 183 | 64 | 4 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 183 | 64 | 4 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.39e-04 | 183 | 64 | 4 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 3991830726d05cf19606d540de04093985b7bdeb | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 184 | 64 | 4 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 184 | 64 | 4 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.42e-04 | 184 | 64 | 4 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | droplet-Mammary_Gland-nan-3m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 02a2cbae9238c6c1e80b9a52a575e3b22f0eebb4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 186 | 64 | 4 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-04 | 186 | 64 | 4 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 186 | 64 | 4 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 187 | 64 | 4 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 187 | 64 | 4 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-04 | 187 | 64 | 4 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 187 | 64 | 4 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.54e-04 | 188 | 64 | 4 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 188 | 64 | 4 | 0a47de24812c619f6756c9351a413b109128d54f | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 1.54e-04 | 188 | 64 | 4 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 189 | 64 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.61e-04 | 190 | 64 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-04 | 191 | 64 | 4 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-04 | 191 | 64 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 192 | 64 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.67e-04 | 192 | 64 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.67e-04 | 192 | 64 | 4 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 192 | 64 | 4 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 192 | 64 | 4 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-04 | 192 | 64 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 192 | 64 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.67e-04 | 192 | 64 | 4 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 192 | 64 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 193 | 64 | 4 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-04 | 193 | 64 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 193 | 64 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.71e-04 | 193 | 64 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | background-Cholangiocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-04 | 193 | 64 | 4 | 9152241073dbe02ac2c11d86bec9b5b529196f6e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-04 | 193 | 64 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.71e-04 | 193 | 64 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 194 | 64 | 4 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 64 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 64 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 194 | 64 | 4 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-04 | 195 | 64 | 4 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 195 | 64 | 4 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 195 | 64 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 195 | 64 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.77e-04 | 195 | 64 | 4 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.77e-04 | 195 | 64 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.81e-04 | 196 | 64 | 4 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 196 | 64 | 4 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 196 | 64 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 196 | 64 | 4 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 196 | 64 | 4 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 1.81e-04 | 196 | 64 | 4 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 196 | 64 | 4 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 196 | 64 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-04 | 196 | 64 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.81e-04 | 196 | 64 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| Drug | p-nitrobenzoyl chloride | 7.54e-06 | 2 | 63 | 2 | CID000008502 | |
| Drug | Albendazole | 7.96e-06 | 46 | 63 | 4 | ctd:D015766 | |
| Drug | Tag Peptide | 1.34e-05 | 17 | 63 | 3 | CID005486959 | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; HL60; HG-U133A | 1.65e-05 | 195 | 63 | 6 | 1985_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.75e-05 | 197 | 63 | 6 | 6935_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; HL60; HG-U133A | 1.80e-05 | 198 | 63 | 6 | 1963_DN | |
| Disease | Adenocarcinoma of lung (disorder) | 5.76e-06 | 206 | 64 | 6 | C0152013 | |
| Disease | fetal alcohol spectrum disorder (biomarker_via_orthology) | 2.77e-05 | 4 | 64 | 2 | DOID:0050696 (biomarker_via_orthology) | |
| Disease | Long QT Syndrome | 2.52e-04 | 11 | 64 | 2 | C0023976 | |
| Disease | retinitis pigmentosa (biomarker_via_orthology) | 3.56e-04 | 13 | 64 | 2 | DOID:10584 (biomarker_via_orthology) | |
| Disease | Prostatic Neoplasms | 3.70e-04 | 616 | 64 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.70e-04 | 616 | 64 | 7 | C0376358 | |
| Disease | anemia (implicated_via_orthology) | 4.77e-04 | 15 | 64 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | superior frontal gyrus volume measurement | 6.93e-04 | 18 | 64 | 2 | EFO_0010329 | |
| Disease | Joubert syndrome 1 | 9.47e-04 | 21 | 64 | 2 | C4551568 | |
| Disease | LEOPARD Syndrome | 1.04e-03 | 22 | 64 | 2 | C0175704 | |
| Disease | Neurodevelopmental Disorders | 1.10e-03 | 93 | 64 | 3 | C1535926 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.24e-03 | 24 | 64 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.24e-03 | 24 | 64 | 2 | C3805278 | |
| Disease | RS-10-hydroxywarfarin measurement | 1.28e-03 | 98 | 64 | 3 | EFO_0803330 | |
| Disease | TEMPS-A questionnaire | 1.35e-03 | 25 | 64 | 2 | EFO_0004783 | |
| Disease | Cholangiocarcinoma | 1.46e-03 | 26 | 64 | 2 | C0206698 | |
| Disease | Sezary Syndrome | 1.57e-03 | 27 | 64 | 2 | C0036920 | |
| Disease | Ciliopathies | 1.78e-03 | 110 | 64 | 3 | C4277690 | |
| Disease | Child Development Disorders, Specific | 1.81e-03 | 29 | 64 | 2 | C0085997 | |
| Disease | Child Development Deviations | 1.81e-03 | 29 | 64 | 2 | C0085996 | |
| Disease | Developmental Disabilities | 1.94e-03 | 30 | 64 | 2 | C0008073 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKVDFLIENDAEKDY | 11 | Q9Y6N9 | |
| EEQLDEEHLESHKKY | 251 | Q9Y2D5 | |
| LAYQFDHFSHEKIKD | 86 | O60242 | |
| ADYDKTLIFNKIHHE | 111 | O75477 | |
| HKLEAVKHNFNLEEY | 1561 | Q8N139 | |
| YLEKYEKVHHFGEDD | 96 | Q68CP9 | |
| DKVHNDAQSFDYDHD | 36 | O43852 | |
| DYFHHLERELAKAEK | 521 | Q96CP6 | |
| ADKYESALEDLHSKH | 546 | Q06278 | |
| DKDYHFKVDNDENEH | 26 | P06748 | |
| IHSKEHFKEKYAVDD | 111 | P12955 | |
| KEEFQIHDELLKAHY | 66 | Q9ULE6 | |
| KDHEKAEFEVHEVYA | 211 | Q9UQ80 | |
| QDYEKAIDYHLKHLA | 296 | P81274 | |
| YKFDFEDDQHKIPCH | 4886 | Q8NEZ4 | |
| FKNKEDQYDHLDAAD | 716 | P34932 | |
| FEINVHEDAKEHEKE | 736 | Q96PY6 | |
| QKFIDADVEERHHAY | 346 | Q9Y3R5 | |
| ADFRNKDEKYNHIDE | 731 | Q92598 | |
| EKEHDYRDEHLDFIQ | 241 | O43237 | |
| EFLEKHKIDFVAHDD | 156 | Q9Y5K3 | |
| DYHQFHEDVKDAQEL | 321 | O60437 | |
| TEEFFHQGDIEKKYH | 381 | Q13946 | |
| DDFIHQHFTEVYKTD | 166 | Q8IXQ5 | |
| HAQEKYDEFDLVLHK | 256 | O75949 | |
| VDHVNDYHVKPEKDA | 186 | Q9BZE0 | |
| RHHEKKSIYNLNEDE | 111 | P78316 | |
| LQKHDRFEESAKAYH | 46 | Q9Y6J0 | |
| EDDYENHDKNLFRKI | 226 | Q8NCB2 | |
| DKKFSAHYDAVEAEL | 46 | Q14320 | |
| QAEEKFEDAYEKLHH | 941 | Q5T1B0 | |
| FEDAYEKLHHTLIKN | 946 | Q5T1B0 | |
| EEKYEKEVHHDIRED | 266 | P78310 | |
| SEHYKAFEDAAEEFH | 191 | P31415 | |
| AKAEAEHDEHYYNAI | 481 | Q6PD62 | |
| QEDEKQKDYSHVRHF | 751 | Q8TEP8 | |
| VTQDDYFKDKRVHHF | 271 | Q92904 | |
| AEAKHQYSIDELKHQ | 201 | Q9H069 | |
| KLEYFINKYAEHSHD | 2716 | Q92736 | |
| DDVVRFLDSKHKNHY | 51 | P60484 | |
| HVKECHQLAYADEAK | 376 | Q96C24 | |
| EKFLEHPEDYVAHEE | 971 | Q5TCS8 | |
| EEKIQNEDYHHELSD | 501 | O94972 | |
| EAKEDSLDEEFFHHK | 681 | Q5JRA6 | |
| LLDKIKSYYENAEHH | 716 | A1L390 | |
| EKFEDENFHYKHDRE | 101 | Q08752 | |
| ESKDDKHGSYEDAVH | 536 | P17987 | |
| QEAKDVYKEHFQDDV | 81 | P43490 | |
| DEIFHDVAYKAKERD | 366 | Q2Y0W8 | |
| SQIHYSYNEEKDEDH | 76 | Q9BVR0 | |
| INDKDDTNEYKHAFE | 501 | Q07889 | |
| LEEAHELSEDHYKKY | 901 | Q07889 | |
| EIDHYCKHSEEIKDN | 61 | Q8N1H7 | |
| EHYENAIEYDCKEEH | 81 | Q01826 | |
| LHDFEEQCVEKYFHE | 1146 | Q9BX84 | |
| HFTVALNEKFDKHYE | 266 | P49888 | |
| RDHYKTEYENKLHDE | 366 | Q8WXW3 | |
| ARHHEAYEVKNGEKF | 156 | Q6ZNG0 | |
| YQHKAGEEAFEKLVH | 206 | Q86XW9 | |
| AEHYLAEKEYDKAVQ | 896 | Q8NDW8 | |
| KAHAEEKSYEHGENA | 181 | Q5TYW1 | |
| DKLEVHRKENYSCHD | 221 | Q9UJU3 | |
| LLKAYHHSFDDEKVD | 591 | Q9H6S0 | |
| EVFHDIAYKAKDRHD | 351 | Q9Y6R1 | |
| FGAYEKKLDDDANHH | 116 | Q68DI1 | |
| EYAHKFVEDIQHDLT | 656 | Q96L42 | |
| YDHHAQEKYEEFESV | 271 | B1AL88 | |
| DEVAIKDAHEKDDFH | 46 | Q13224 |